Colin Bain Takes Charge as Chief Products Officer at Owens & Minor

Owens & Minor Welcomes Colin Bain as Chief Products Officer

On March 30, 2026, Owens & Minor, a global leader in healthcare solutions, appointed Colin Bain as its Chief Products Officer (CPO). This strategic move comes as the company aims to expand and innovate its product offerings tailored for various healthcare sectors. Bain, who brings an impressive 35-year background in medical device manufacturing, healthcare services, and consumer goods, is poised to drive the company’s mission forward.

Colin Bain's career is decorated with substantial experience in rapidly evolving markets. He has previously held leadership roles in both large-scale public companies and nimble startups, including a significant stint as a partner at Javelyst Healthcare Challengers. Notably, Bain led Premier’s S2S Global manufacturing company as president, where he implemented effective supply chain programs. His expertise in scaling product portfolios and enhancing business resilience aligns perfectly with Owens & Minor's objectives.

In his new role, Bain will focus on accelerating the growth of the Owens & Minor product portfolio, effectively addressing the needs of customers across acute and non-acute healthcare sectors. Under his leadership, the company looks to ensure continued competitiveness in an ever-changing environment. Christian Cook, chairman and interim CEO of Owens & Minor, expressed enthusiasm about Bain's appointment, mentioning, "Colin’s passion for leveraging innovation to amplify supply chain resilience will be vital to our growth strategy. With Bain at the helm of product development, we look forward to the next chapter in our corporate journey."

In a statement regarding his new position, Bain commented, "Joining Owens & Minor aligns with my commitment to excellence in providing clinical-grade products. I am excited to be part of a company that supports healthcare in every environment and enhances patient care."

Owens & Minor has been a trusted partner in healthcare for over 140 years, delivering quality products and services that uphold medical excellence. Just recently, the company entered a new phase after being integrated into the Platinum Equity portfolio, becoming a standalone entity. This organizational shift signals a renewed focus on delivering high-performance solutions in healthcare.

With Bain’s extensive experience and Owens & Minor’s established reputation, the future looks promising for the company. Bain’s leadership will likely drive innovation and adapt to the myriad challenges within the healthcare landscape, ultimately benefitting patients and healthcare providers alike. The company's ongoing dedication to enhancing service delivery and product quality is sure to evolve under Bain's guidance.

As Owens & Minor continues to define its legacy, the appointment of Colin Bain as Chief Products Officer marks a pivotal step in aligning the company's strategic vision with market demands. The healthcare sector is fast-paced, and Bain's strategic insights will be crucial in navigating the complexities ahead. With over 14,000 employees around the globe, Owens & Minor remains steadfast in its mission, ensuring that every day, everywhere, providers can trust in their products and services to enhance patient care.

Colin Bain's appointment is not just a new role but a promise of innovation, excellence, and resilience for Owens & Minor. As the company embarks on this new chapter, it’s evident that effective leadership will play a crucial role in maintaining its standard of excellence and pushing the boundaries of what's possible in healthcare.

About Owens & Minor

Owens & Minor is dedicated to providing essential products and technology solutions to support healthcare delivery globally. With deep-rooted values and a commitment to service, the company continues to work towards elevating the standards of care provided in healthcare settings worldwide.